(Q69908450)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899596%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899596%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

J T Noble

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899596%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

M Barza

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899596%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 September 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899596%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899596%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899596%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899596%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

175-181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3899596%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-198530030-00001

6 October 2019

exact match

0 references

cites work

Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function

1 reference

12 December 2020

Antimicrobial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime: Evidence of Synergy

1 reference

12 December 2020

Comparative Multiple-Dose Pharmacokinetics of Cefotaxime, Moxalactam, and Ceftazidime

1 reference

12 December 2020

Cefotaxime concentrations in ascites

1 reference

12 December 2020

Mechanism of the inhibition of the gamma-carboxylation of glutamic acid by N-methylthiotetrazole-containing antibiotics

1 reference

12 December 2020

Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Effect of Broad-Spectrum Cephalosporins on the Microbial Flora of Recipients

1 reference

12 December 2020

Interaction between moxalactam and alcohol

1 reference

12 December 2020

Ceftriaxone A Review of its Antibacterial Activity, Pharmacological Properties and Therapeutic Use

1 reference

12 December 2020

Moxalactam--absorption, excretion, distribution, and metabolism

1 reference

12 December 2020

Effects of Moxalactam on Blood Coagulation and Platelet function

1 reference

12 December 2020

Moxalactam (Latamoxef) A Review of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Use

1 reference

12 December 2020

Influence of third-generation cephalosporins on aerobic intestinal flora

1 reference

12 December 2020

Clinical adverse effects during ceftriaxone therapy

1 reference

12 December 2020

Pharmacokinetics of ceftizoxime in patients undergoing hemodialysis

1 reference

12 December 2020

The new beta-lactamase-stable cephalosporins

1 reference

12 December 2020

Penetration of ceftizoxime (FK 749) into the cerebrospinal fluid (author's transl)

1 reference

12 December 2020

Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora

1 reference

12 December 2020

Studies on absorption, distribution, metabolism and excretion of ceftazidime in Japan

1 reference

12 December 2020

Cefotaxime A review of its Antibacterial Activity, Pharmacological Properties and Therapeutic Use

1 reference

12 December 2020

Effect of cefoperazone on faecal flora

1 reference

12 December 2020

Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy

1 reference

12 December 2020

Tissue penetration characteristics of ceftizoxime and cefazolin in human bile and gallbladder wall

1 reference

12 December 2020

Pharmacokinetic profile of ceftriaxone in man.

1 reference

12 December 2020

Antimicrobial activity, pharmacokinetics, adverse reactions, and therapeutic indications of cefoperazone

1 reference

12 December 2020

Mechanism of Action, Antimicrobial Activity, Pharmacology, Adverse Effects, and Clinical Efficacy of Cefotaxime

1 reference

12 December 2020

Prolonged Bleeding Times and Bleeding Diathesis Associated With Moxalactam Administration

1 reference

12 December 2020

Pharmacokinetics of moxalactam in subjects with normal and impaired renal function

1 reference

12 December 2020

Ceftizoxime: a beta-lactamase-stable, broad-spectrum cephalosporin. Pharmacokinetics, adverse effects and clinical use.

1 reference

12 December 2020

Hypoprothrombinemia in febrile, neutropenic patients with cancer: association with antimicrobial suppression of intestinal microflora

1 reference

12 December 2020

Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism

1 reference

12 December 2020